Literature DB >> 18669927

Does inhibition of glycogen synthase kinase protect in mice?

Elizabeth Murphy1, Charles Steenbergen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669927      PMCID: PMC2617729          DOI: 10.1161/CIRCRESAHA.108.181602

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  8 in total

1.  Inhibition of glycogen synthase kinase enhances isoflurane-induced protection against myocardial infarction during early reperfusion in vivo.

Authors:  Paul S Pagel; John G Krolikowski; Donald A Neff; Dorothee Weihrauch; Martin Bienengraeber; Judy R Kersten; David C Warltier
Journal:  Anesth Analg       Date:  2006-05       Impact factor: 5.108

Review 2.  Preconditioning: the mitochondrial connection.

Authors:  Elizabeth Murphy; Charles Steenbergen
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

3.  Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective.

Authors:  Haiyan Tong; Kenichi Imahashi; Charles Steenbergen; Elizabeth Murphy
Journal:  Circ Res       Date:  2002-03-08       Impact factor: 17.367

4.  Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts.

Authors:  Eric R Gross; Anna K Hsu; Garrett J Gross
Journal:  Circ Res       Date:  2004-02-19       Impact factor: 17.367

5.  Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse.

Authors:  Yasuhiro Nishino; Ian G Webb; Sean M Davidson; Aminul I Ahmed; James E Clark; Sebastien Jacquet; Ajay M Shah; Tetsuji Miura; Derek M Yellon; Metin Avkiran; Michael S Marber
Journal:  Circ Res       Date:  2008-06-26       Impact factor: 17.367

6.  Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore.

Authors:  Magdalena Juhaszova; Dmitry B Zorov; Suhn-Hee Kim; Salvatore Pepe; Qin Fu; Kenneth W Fishbein; Bruce D Ziman; Su Wang; Kirsti Ytrehus; Christopher L Antos; Eric N Olson; Steven J Sollott
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

7.  Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.

Authors:  Ludovic Gomez; Mélanie Paillard; Hélène Thibault; Geneviève Derumeaux; Michel Ovize
Journal:  Circulation       Date:  2008-05-19       Impact factor: 29.690

8.  Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death.

Authors:  Christopher P Baines; Robert A Kaiser; Tatiana Sheiko; William J Craigen; Jeffery D Molkentin
Journal:  Nat Cell Biol       Date:  2007-04-08       Impact factor: 28.824

  8 in total
  14 in total

1.  Aldose reductase modulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion.

Authors:  Mariane Abdillahi; Radha Ananthakrishnan; Srinivasan Vedantham; Linshan Shang; Zhengbin Zhu; Rosa Rosario; Hylde Zirpoli; Kurt M Bohren; Kenneth H Gabbay; Ravichandran Ramasamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-01       Impact factor: 4.733

Review 2.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 3.  Role of glycogen synthase kinase-3beta in cardioprotection.

Authors:  Magdalena Juhaszova; Dmitry B Zorov; Yael Yaniv; H Bradley Nuss; Su Wang; Steven J Sollott
Journal:  Circ Res       Date:  2009-06-05       Impact factor: 17.367

4.  Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanism.

Authors:  Feng Ren; Zhongping Duan; Qiao Cheng; Xiuda Shen; Feng Gao; Li Bai; Jun Liu; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Yuan Zhai
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

5.  Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.

Authors:  Kathleen C Woulfe; Erhe Gao; Hind Lal; David Harris; Qian Fan; Ronald Vagnozzi; Morgan DeCaul; Xiying Shang; Satish Patel; James R Woodgett; Thomas Force; Jibin Zhou
Journal:  Circ Res       Date:  2010-04-01       Impact factor: 17.367

Review 6.  Targeting GSK-3 family members in the heart: a very sharp double-edged sword.

Authors:  Hui Cheng; James Woodgett; Mia Maamari; Thomas Force
Journal:  J Mol Cell Cardiol       Date:  2010-12-13       Impact factor: 5.000

Review 7.  The GSK-3 family as therapeutic target for myocardial diseases.

Authors:  Hind Lal; Firdos Ahmad; James Woodgett; Thomas Force
Journal:  Circ Res       Date:  2015-01-02       Impact factor: 17.367

8.  Selective blockade of protein kinase B protects the rat and human myocardium against ischaemic injury.

Authors:  José Linares-Palomino; Muhammad A Husainy; Vien K Lai; John M Dickenson; Manuel Galiñanes
Journal:  J Physiol       Date:  2010-04-19       Impact factor: 5.182

9.  Characterization and functional expression of the natriuretic peptide system in human lens epithelial cells.

Authors:  Patrick R Cammarata; Brittany Braun; Slobodan D Dimitrijevich; Jessica Pack
Journal:  Mol Vis       Date:  2010-04-09       Impact factor: 2.367

10.  Cardioprotection leads to novel changes in the mitochondrial proteome.

Authors:  Renee Wong; Angel M Aponte; Charles Steenbergen; Elizabeth Murphy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-23       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.